| Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings LA Bero, R Grilli, JM Grimshaw, E Harvey, AD Oxman, MA Thomson Bmj 317 (7156), 465-468, 1998 | 2779 | 1998 |
| Pharmaceutical industry sponsorship and research outcome and quality: systematic review J Lexchin, LA Bero, B Djulbegovic, O Clark bmj 326 (7400), 1167-1170, 2003 | 2690 | 2003 |
| Changing provider behavior: an overview of systematic reviews of interventions JM Grimshaw, L Shirran, R Thomas, G Mowatt, C Fraser, L Bero, R Grilli, ... Medical care 39 (8), II-2-II-45, 2001 | 2379 | 2001 |
| Industry sponsorship and research outcome A Lundh, J Lexchin, B Mintzes, JB Schroll, L Bero Cochrane database of systematic reviews, 2017 | 1954 | 2017 |
| The cigarette papers SA Glantz Univ of California Press, 1996 | 816 | 1996 |
| Coverage by the news media of the benefits and risks of medications R Moynihan, L Bero, D Ross-Degnan, D Henry, K Lee, J Watkins, C Mah, ... New England journal of medicine 342 (22), 1645-1650, 2000 | 713 | 2000 |
| The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care L Bero, D Rennie Jama 274 (24), 1935-1938, 1995 | 698 | 1995 |
| Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials A Anglemyer, HT Horvath, L Bero Cochrane Database of Systematic Reviews, 2014 | 692 | 2014 |
| Why review articles on the health effects of passive smoking reach different conclusions DE Barnes, LA Bero Jama 279 (19), 1566-1570, 1998 | 666 | 1998 |
| Effect of outpatient pharmacists' non‐dispensing roles on patient outcomes and prescribing patterns N Nkansah, O Mostovetsky, C Yu, T Chheng, J Beney, CM Bond, L Bero Cochrane database of systematic reviews, 2010 | 472 | 2010 |
| Getting research findings into practice: closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of … LA Bero, R Grilli, JM Grimshaw, E Harvey, AD Oxman, MA Thomson BMJ: British Medical Journal 317 (7156), 465, 1998 | 462 | 1998 |
| Narrative review: the promotion of gabapentin: an analysis of internal industry documents MA Steinman, LA Bero, MM Chren, CS Landefeld Annals of Internal Medicine 145 (4), 284-293, 2006 | 439 | 2006 |
| The quality of drug studies published in symposium proceedings MK Cho, LA Bero Annals of Internal Medicine 124 (5), 485-489, 1996 | 431 | 1996 |
| Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation K Rising, P Bacchetti, L Bero PLoS medicine 5 (11), e217, 2008 | 417 | 2008 |
| Printed educational materials: effects on professional practice and health care outcomes N Freemantle, EL Harvey, F Wolf, JM Grimshaw, R Grilli, LA Bero Cochrane Database Syst Rev 2, CD000172, 2000 | 417 | 2000 |
| Outcome reporting in industry-sponsored trials of gabapentin for off-label use SS Vedula, L Bero, RW Scherer, K Dickersin New England Journal of Medicine 361 (20), 1963-1971, 2009 | 405 | 2009 |
| Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. LA Bero, NB Mays, K Barjesteh, C Bond The Cochrane Database of Systematic Reviews, CD000336-CD000336, 2000 | 393 | 2000 |
| Systematic reviews of the effectiveness of quality improvement strategies and programmes J Grimshaw, LM McAuley, LA Bero, R Grilli, AD Oxman, C Ramsay, L Vale, ... BMJ Quality & Safety 12 (4), 298-303, 2003 | 386 | 2003 |
| Influences on the quality of published drug studies LA Bero, D Rennie International journal of technology assessment in health care 12 (2), 209-237, 1996 | 340 | 1996 |
| Implications of the tobacco industry documents for public health and policy L Bero Annual review of public health 24 (1), 267-288, 2003 | 335 | 2003 |
